Parallax Volatility Advisers’s VistaGen Therapeutics VTGN Stock Holding History

Parallax Volatility Advisers’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,504	Closed	-$13.1K	–	2902
2023 Q1	$13.1K	Hold	3,504	–	–	﹤0.01%	2367
2022 Q4	$10.8K	Sell	3,504 -166	-5%	-$625	﹤0.01%	2558
2022 Q3	$17K	Buy	3,670 +1,235	+51%	+$12.2K	﹤0.01%	2765
2022 Q2	$64K	Sell	2,435 -393	-14%	-$13.9K	﹤0.01%	2428
2022 Q1	$105K	Sell	2,828 -337	-11%	-$14.7K	﹤0.01%	2345
2021 Q4	$185K	Buy	3,165 +1,684	+114%	+$110K	﹤0.01%	1666
2021 Q3	$122K	Hold	1,481	–	–	﹤0.01%	1758
2021 Q2	$140K	Hold	1,481	–	–	﹤0.01%	1329
2021 Q1	$95K	Hold	1,481	–	–	﹤0.01%	1139
2020 Q4	$86K	Hold	1,481	–	–	﹤0.01%	1982
2020 Q3	$31K	Hold	1,481	–	–	﹤0.01%	2907
2020 Q2	$23K	Hold	1,481	–	–	﹤0.01%	2567
2020 Q1	$20K	Hold	1,481	–	–	﹤0.01%	2329
2019 Q4	$31K	Hold	1,481	–	–	﹤0.01%	2264
2019 Q3	$48K	Hold	1,481	–	–	﹤0.01%	2086
2019 Q2	$32K	Hold	1,481	–	–	﹤0.01%	2036
2019 Q1	$57K	Hold	1,481	–	–	﹤0.01%	2242
2018 Q4	$67K	Hold	1,481	–	–	﹤0.01%	2040
2018 Q3	$64K	Hold	1,481	–	–	﹤0.01%	1797
2018 Q2	$61K	Hold	1,481	–	–	﹤0.01%	1530
2018 Q1	$41K	Hold	1,481	–	–	﹤0.01%	1611
2017 Q4	$49K	Sell	1,481 -7,714	-84%	-$255K	﹤0.01%	3240
2017 Q3	$441K	Hold	9,195	–	–	﹤0.01%	1285
2017 Q2	$516K	Hold	9,195	–	–	﹤0.01%	1218
2017 Q1	$541K	Sell	9,195 -253	-3%	-$20.5K	﹤0.01%	1452
2016 Q4	$1.06M	Sell	9,448 -285	-3%	-$33.2K	﹤0.01%	1201
2016 Q3	$1.24M	Sell	9,733 -70	-0.7%	-$7.6K	﹤0.01%	1172
2016 Q2	$1.15M	Buy	+9,803	New	+$1.12M	﹤0.01%	1144

Other funds holding VTGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's VTGN Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of VistaGen Therapeutics (VTGN) in Q2 2023, closing a stake of 3,504 shares — an estimated $13.1K sold.

Parallax Volatility Advisers first reported a position in VTGN in Q2 2016 and held it in 28 quarters. The position peaked at $1.24M in Q3 2016. 33 funds tracked by Wall St. Rank hold VTGN as of Q2 2023.

Parallax Volatility Advisers reported no remaining VistaGen Therapeutics position as of Q2 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 3,504 VistaGen Therapeutics shares in Q2 2023, an estimated $13.1K.
Parallax Volatility Advisers first reported a position in VistaGen Therapeutics in Q2 2016 and held it in 28 quarters.
Parallax Volatility Advisers's VistaGen Therapeutics position peaked at $1.24M in Q3 2016.
33 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.